Publications

Detailed Information

Immunohistochemical and Molecular Characteristics of Follicular Patterned Thyroid Nodules with Incomplete Nuclear Features of Papillary Thyroid Carcinoma

DC Field Value Language
dc.contributor.authorMin, Hye Sook-
dc.contributor.authorChoe, Gheeyoung-
dc.contributor.authorCho, Nam-Yun-
dc.contributor.authorKang, Gyeong Hoon-
dc.contributor.authorPark, So Yeon-
dc.contributor.authorPark, Seong Hoe-
dc.date.accessioned2012-06-04T00:49:00Z-
dc.date.available2012-06-04T00:49:00Z-
dc.date.issued2009-
dc.identifier.citationKOREAN JOURNAL OF PATHOLOGY; Vol.43 6; 495-502ko_KR
dc.identifier.issn1738-1843-
dc.identifier.urihttps://hdl.handle.net/10371/76741-
dc.description.abstractBackground : Follicular patterned thyroid nodules with incomplete nuclear features of papillary thyroid carcinoma (FTN-INPTCs) are difficult to diagnose, and their biological behavior and association with follicular variants of PTC (FVPTCs) have not yet been established. The aim of this study is to determine immunohistochemical and molecular characteristics of FTN-INPTCs. Methods : We investigated immunohistochemical features (galectin-3, HBME-1, CK19, fibronectin-1, CITED1), BRAF V600E mutation and RASSF1A promoter methylation status in 30 FTN-INPTC cases, along with 26 FVPTCs, 21 follicular adenomas (FAs) and 14 nodular hyperplasias (NHs). Results : Expression of galectin-3, HBME-1, CK19 and CITED1 was significantly higher in FTN-INPTCs than in FAs or NHs, but expression of galectin-3, CK19 and fibronectin-1 was lower in FTN-INPTCs than in FVPTCs. The BRAF V600E mutation was not detected in the benign nodules or FTN-INPTCs, whereas 57% of FVPTCs had the mutation. RASSF1A promoter methylation was higher in FTN-INPTCs than in benign nodules but there was no difference between FTN-INPTCs and FVPTCs. Conclusions : Our results represent the borderline immunohistochemical and molecular characteristics of FTN-INPTC. We conclude that FTN-INPTC is an intermediate lesion between a benign nodule and a FVPTC, and that it is pathogenetically related to FVPTC.ko_KR
dc.description.sponsorshipThis work was supported by the Korea Research
Foundation Grant funded by the Korean Government
(MOEHRD) (KRF-2006- 331-E00050).
ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN SOCIETY PATHOLOGISTSko_KR
dc.subjectThyroid glandko_KR
dc.subjectThyroid neoplasmsko_KR
dc.subjectCarcinomako_KR
dc.subjectPapillaryko_KR
dc.titleImmunohistochemical and Molecular Characteristics of Follicular Patterned Thyroid Nodules with Incomplete Nuclear Features of Papillary Thyroid Carcinomako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor민혜숙-
dc.contributor.AlternativeAuthor최기영-
dc.contributor.AlternativeAuthor조남윤-
dc.contributor.AlternativeAuthor강경훈-
dc.contributor.AlternativeAuthor박성회-
dc.contributor.AlternativeAuthor박소연-
dc.identifier.doi10.4132/KoreanJPathol.2009.43.6.495-
dc.citation.journaltitleKOREAN JOURNAL OF PATHOLOGY-
dc.description.citedreferenceArora N, 2008, WORLD J SURG, V32, P1237, DOI 10.1007/s00268-008-9484-1-
dc.description.citedreferencePark YJ, 2007, J KOREAN MED SCI, V22, P621-
dc.description.citedreferenceCHAN JKC, 2007, DIAGNOSTIC HISTOPATH, P997-
dc.description.citedreferenceRhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240-
dc.description.citedreferencede Matos PS, 2005, HISTOPATHOLOGY, V47, P391, DOI 10.1111/j.1365-2559.2005.02221.x-
dc.description.citedreferenceNakamura N, 2005, LAB INVEST, V85, P1065, DOI 10.1038/labinvest.3700306-
dc.description.citedreferenceXing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978-
dc.description.citedreferencePapotti M, 2005, MODERN PATHOL, V18, P541, DOI 10.1038/modpathol.3800321-
dc.description.citedreferencePrasad ML, 2005, MODERN PATHOL, V18, P48, DOI 10.1038/modpathol.3800235-
dc.description.citedreferenceWeisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987-
dc.description.citedreferenceVasko VV, 2004, EUR J ENDOCRINOL, V151, P779-
dc.description.citedreferenceKim KH, 2004, YONSEI MED J, V45, P818-
dc.description.citedreferenceGasbarri A, 2004, BRIT J CANCER, V91, P1096, DOI 10.1038/sj.bjc.6602097-
dc.description.citedreferenceXing MZ, 2004, CANCER RES, V64, P1664-
dc.description.citedreferenceKimura ET, 2003, CANCER RES, V63, P1454-
dc.description.citedreferenceHirokawa M, 2002, AM J SURG PATHOL, V26, P1508-
dc.description.citedreferenceSchagdarsurengin U, 2002, CANCER RES, V62, P3698-
dc.description.citedreferenceFusco A, 2002, AM J PATHOL, V160, P2157-
dc.description.citedreferenceShivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002-
dc.description.citedreferenceColi A, 2002, HISTOPATHOLOGY, V40, P80-
dc.description.citedreferenceBartolazzi A, 2001, LANCET, V357, P1644-
dc.description.citedreferenceEads CA, 2001, CANCER RES, V61, P3410-
dc.description.citedreferenceWilliams ED, 2000, INT J SURG PATHOL, V8, P181-
dc.description.citedreferenceOrlandi F, 1998, CANCER RES, V58, P3015-
dc.description.citedreferenceSack MT, 1997, MODERN PATHOL, V10, P668-
dc.description.citedreferenceHerman JG, 1996, P NATL ACAD SCI USA, V93, P9821-
dc.description.citedreferenceOKAYASU I, 1995, CANCER, V76, P2312-
dc.description.citedreferenceBERHO M, 1995, ANN CLIN LAB SCI, V25, P513-
dc.description.citedreferenceRAPHAEL SJ, 1994, MODERN PATHOL, V7, P295-
dc.description.citedreferenceROSAI J, 1992, ATLAS TUMOR PATHOL, P65-
dc.description.tc1-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share